The Centers for Medicare and Medicaid Services recently proposed regulations that would explore requiring PBMs in Medicare Part D to account for pharmacy DIR fees at point of sale. CMS says that while the proposal would lead to modest increases in monthly premiums, these would be more than offset by savings at the pharmacy counter. According to CMS, it would result in net patient savings of $10.4 billion over 10 years.
Please take a moment and submit a public comment supporting the DIR proposal and other pharmacy-friendly provisions of the proposed rule, and encourage CMS to finalize that language. Click here to submit a comment. Please personalize the message with your own experiences.
NCPA will also be submitting comments to CMS. If you are a pharmacy owner/manager, please take a few moments to complete a brief survey and let us know how DIR fees are impacting you and your patients. Your input will help guide our comments.